January 26, 2022 by Jason Wertheimer Sonoma Bio Co-Founder and Chief Executive Officer Jeffrey Bluestone, Ph.D., Receives Top Scientific Honors Learn More
August 4, 2021 by Jason Wertheimer Endpoints News Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how Learn More
July 14, 2021 by Jason Wertheimer Nature Creating T cells to guard against autoimmune disease Learn More
October 1, 2020 by Jason Wertheimer LinkedIn The time is now: Autoimmune and inflammatory diseases, meet regulatory T-cell therapy Learn More
September 30, 2020 by Jason Wertheimer Endpoints News Sonoma Bio named as one of most promising startups in biotech by Endpoints News Learn More